Biosimilars: Economic Issues for IP Litigation
In July 2021, the U.S. Food and Drug Administration granted a determination of interchangeability to a biosimilar drug for the first time. This approval has...
Speaking Engagement
2nd Annual Summit on Life Sciences IP Due Diligence
November 29-30, 2018
Park Plaza Hotel, Boston, Massachusetts
Meet the presenters
![Gregory Bell | Expert Witness | Charles River Associates]()
Gregory K. BellGroup Vice President and Life Sciences Practice Leader
Boston
+1-617-425-3357 gbell@crai.com
Upcoming Events
IAM/GCR SEP Summit 2021
CRA is a proud sponsor of this event. Larry Rosenberg conducts a roundtable discussion titled “Are licensing negotiation groups a suitable solution for SEP...
Fordham’s 48th Annual Conference on International Antitrust Law and Policy
CRA is a proud sponsor of this event. Tim Simcoe moderates and Fei Deng speaks as a panelist during the session titled “What Next for New Madison? Current...